The only CSC marker that was consistently reliable across all tumor entities was CD90, and thus, the remaining tumors (up to 145) were analyzed for AF and CD90, as well as EpCAM (Fig. 2B and C). The gene discussed is EPCAM; the disease is neoplasm.